| DWS INVEST CROCI GLOBAL DIVIDENDS USD LDQ | RVI GLOBAL | 29,98% | 40,24% | 51,00% | · |
| WELLINGTON GLOBAL HEALTH CARE EQUITY FUND USD T ACC | RVI SALUD | 29,98% | · | · | · |
| NINETY ONE GSF GLOBAL NATURAL RESOURCES FUND A ACC EUR | RVI MATERIAS PRIMAS | 29,96% | 66,14% | 108,48% | · |
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) I-B-ACC | RVI EUROPA CRECIMIENTO | 29,96% | 91,32% | 111,88% | · |
| FAST-GLOBAL CONTRARIAN LONG/SHORT FUND I-PF-ACC-EUR H | RENT. ABSOLUTA. | 29,95% | · | · | · |
| MFS MERIDIAN CONTRARIAN VALUE FUND N1-USD | RVI GLOBAL VALOR | 29,95% | 79,20% | 102,24% | · |
| MFS MERIDIAN CONTRARIAN CAPITAL FUND IF1-USD | RVI GLOBAL VALOR | 29,94% | · | · | · |
| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) Q-ACC | RVI GLOBAL VALOR | 29,94% | 68,21% | 85,01% | 164,08% |
| JPM EUROPE STRATEGIC VALUE C (ACC) USD (HEDGED) | RVI EUROPA VALOR | 29,93% | 92,94% | 130,55% | · |
| MAN ALTERNATIVE STYLE RISK PREMIA I H AUD | RENT. ABSOLUTA. | 29,93% | 38,02% | 52,93% | · |
| VALENTUM, FI E | RVI GLOBAL VALOR | 29,93% | 71,96% | 22,97% | 160,53% |
| AB SICAV I-US VALUE PORTFOLIO A EUR | RVI USA VALOR | 29,91% | · | · | · |
| DWS INVEST CROCI EURO LC | RV EURO | 29,90% | 55,03% | 45,38% | · |
| SCHRODER ISF SWISS EQUITY A ACC GBP (HEDGED) | RVI SUIZA | 29,90% | 61,47% | 35,79% | 139,73% |
| WELLINGTON GLOBAL STEWARDS FUND USD S ACC | RVI GLOBAL | 29,90% | 64,01% | 73,00% | · |
| EDMOND DE ROTHSCHILD GOLDSPHERE R EUR | RVI MATERIAS PRIMAS | 29,88% | 262,22% | 193,09% | 291,12% |
| PICTET - BIOTECH R USD | RVI BIOTECNOLOGÍA | 29,88% | 106,87% | 54,10% | 121,46% |
| UBS (LUX) EQUITY SICAV - EUROPEAN OPPORTUNITY UNCONSTRAINED (EUR) (USD HEDGED) P-ACC | RVI EUROPA | 29,88% | 46,47% | 41,99% | 166,96% |
| T.ROWE US LARGE CAP VALUE EQUITY FUND IN1 (EUR) | RVI USA | 29,87% | 62,66% | · | · |
| ISHARES MSCI EM EX-CHINA UCITS ETF USD (ACC) | RVI EMERGENTES | 29,86% | 82,07% | 68,51% | · |
| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | RVI BIOTECNOLOGÍA | 29,84% | 113,02% | 92,47% | 346,98% |
| POLAR CAPITAL HEALTHCARE DISCOVERY I USD CAP | RVI SALUD | 29,84% | 61,16% | 12,69% | · |
| SCHRODER ISF GLOBAL EQUITY YIELD IZ ACC USD | RVI GLOBAL VALOR | 29,84% | 64,93% | 78,52% | · |
| WELLINGTON GLOBAL STEWARDS FUND USD UN ACC | RVI GLOBAL | 29,84% | 63,77% | · | · |
| CANDRIAM EQUITIES L ONCOLOGY N CAP EUR | RVI SALUD | 29,83% | 46,37% | · | · |
| GOLDMAN SACHS COMMODITY ENHANCED X CAP USD | RVI MATERIAS PRIMAS | 29,83% | 39,37% | 48,78% | 79,73% |
| WELLINGTON GLOBAL QUALITY VALUE FUND E USD ACC | RVI GLOBAL VALOR | 29,81% | 62,46% | · | · |
| MAN JAPAN COREALPHA EQUITY I H EUR | RVI JAPÓN | 29,79% | 105,38% | 221,12% | 311,91% |
| CT (LUX) ENHANCED COMMODITIES DU USD | RVI MATERIAS PRIMAS | 29,78% | 43,42% | 64,90% | 78,32% |
| SCHRODER ISF GLOBAL EQUITY YIELD C ACC EUR | RVI GLOBAL VALOR | 29,78% | 64,14% | 76,53% | 148,74% |
| CPR INVEST GLOBAL RESOURCES F USD ACC | RVI MATERIAS PRIMAS | 29,77% | 54,74% | 61,19% | · |
| FRANKLIN NATURAL RESOURCES N (ACC) EUR | RVI MATERIAS PRIMAS | 29,77% | 51,50% | 95,32% | 63,93% |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS J1 JPY | RENT. ABSOLUTA. | 29,77% | 50,34% | 27,68% | · |
| SCHRODER ISF EMERGING EUROPE C DIS EUR | RVI EMERGENTES EUROPA | 29,76% | · | -33,39% | 15,32% |
| GSQUARTIX MODIFIED STRATEGY ON THE BLOOMBERG COMMODITY INDEX TOTAL RETURN PORTFOLIO A (USD) | RVI MATERIAS PRIMAS | 29,75% | 39,65% | 65,40% | 113,25% |
| GSQUARTIX MODIFIED STRATEGY ON THE BLOOMBERG COMMODITY INDEX TOTAL RETURN PORTFOLIO I (USD) | RVI MATERIAS PRIMAS | 29,75% | 39,65% | 65,40% | 113,27% |
| WELLINGTON GLOBAL STEWARDS FUND USD N ACC | RVI GLOBAL | 29,71% | 63,28% | 71,67% | · |
| JANUS HENDERSON GLOBAL LIFE SCIENCES A2 USD | RVI BIOTECNOLOGÍA | 29,68% | 58,05% | 49,80% | 173,77% |
| MFS MERIDIAN CONTRARIAN VALUE FUND C1-USD | RVI GLOBAL VALOR | 29,67% | 77,85% | 99,74% | · |
| CANDRIAM EQUITIES L ONCOLOGY C CAP USD | RVI SALUD | 29,65% | 47,62% | 25,47% | · |
| MAN JAPAN COREALPHA EQUITY IXU USD | RVI JAPÓN | 29,65% | · | · | · |
| MAN JAPAN COREALPHA EQUITY IXX JPY | RVI JAPÓN | 29,65% | 77,38% | 121,31% | · |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS | RVI BIOTECNOLOGÍA | 29,64% | 111,28% | 89,83% | 338,57% |
| SCHRODER ISF COMMODITY C ACC USD | RVI MATERIAS PRIMAS | 29,64% | 40,15% | 55,05% | · |
| DWS INVEST CROCI JAPAN USD ICH | RVI JAPÓN | 29,62% | 77,93% | 177,86% | · |
| M&G (LUX) EUROPEAN STRATEGIC VALUE FUND USD C-H DIS | RVI EUROPA VALOR | 29,62% | · | · | · |
| DWS CONCEPT NISSAY JAPAN VALUE EQUITY JPY XC | RVI JAPÓN VALOR | 29,60% | · | · | · |
| SCHRODER ISF US SMALLER COMPANIES IMPACT IZ ACC USD | RVI USA SMALL/MID CAP | 29,60% | 67,44% | 41,70% | · |
| NEUBERGER BERMAN JAPAN EQUITY ENGAGEMENT USD I ACC (HEDGED) | RVI JAPÓN SMALL/MID CAP | 29,57% | · | · | · |
| ISHARES DIVERSIFIED COMMODITY SWAP UCITS ETF (DE) | RVI MATERIAS PRIMAS | 29,56% | 38,84% | 56,56% | 81,43% |
